Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Atogepant: Mechanism of action, clinical and translational science

1 Jan 2024

Abstract excerpt

Since the discovery of calcitonin gene-related peptide (CGRP) in 1982, its integral role in migraine pathophysiology, specifically migraine pain, has been demonstrated through cumulative scientific discoveries that have led to the development and approval of migraine-specific therapeutics. Today, eight drugs, including monoclonal antibodies and small molecule CGRP receptor antagonists, known as gepants, have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Migraine and Headache Studies
Share to Sympathectomy and Hyperhidrosis Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38266063
DOI: 10.1111/cts.13707

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Atogepant: Mechanism of action, clinical and translational sciencePMID 38266063Read ↗

Migraine Treatment: Towards New Pharmacological TargetsSemantic proximity Read ↗

Effectiveness and Tolerability of Anti-Calcitonin Gene-related Peptide Therapy for Migraines and Other Chronic Headaches in Adolescents and Young Adults: A Retrospective Study in the USASemantic proximity Read ↗

Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Highly Sensitive Assays for detection of headache inducing neuropeptides, Pituitary adenylate cyclase-activating polypeptide (PACAP) and Calcitonin gene-related peptide (CGRP)Semantic proximity Read ↗

Treating episodic migraine with precision: the evolving landscape of targeted therapies driven by insights in disease biologySemantic proximity Read ↗

Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity Read ↗

From CGRP to PACAP: Unraveling the Next Chapter in Migraine TreatmentSemantic proximity Read ↗

Cluster headache: new targets and options for treatmentSemantic proximity Read ↗

Effect of Calcitonin Gene-Related Peptide Receptor Antagonists on Migraine Treatment: A Meta-AnalysisSemantic proximity Read ↗

Different Doses of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Network Meta-AnalysisSemantic proximity Read ↗

An Investigation into the Prevalence of Migraine and its Prophylactic Treatment Patterns in the Czech RepublicSemantic proximity Read ↗

Novel Calcitonin Gene-Related Peptide (CGRP) Interfering Migraine Therapies and Stroke – A ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.